6127.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (2 5月 2024 @ 15:02):

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally...

Stats
本日の出来高	549 220
平均出来高	1.50M
時価総額	12.67B
EPS	HKD0.270 ( 2024-01-10 )
Last Dividend	HKD0.440 ( 2023-06-20 )
Next Dividend	HKD0 ( N/A )
P/E	15.19
ATR14	HKD0.0170 (0.20%)

ボリューム相関

長: 0.01 (neutral)

短: 0.67 (moderate)

Signal:(72.141) Neutral

Joinn Laboratories 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Joinn Laboratories 相関 - 通貨/商品

-0.66
( moderate negative )

-0.38
( neutral )

0.00
( neutral )

-0.65
( weak negative )

0.61
( weak )

Joinn Laboratories 財務諸表

Annual	2023
収益:	HKD2.38B
総利益:	HKD1.01B (42.62 %)
EPS:	HKD0.530

FY	2023
収益:	HKD2.38B
総利益:	HKD1.01B (42.62 %)
EPS:	HKD0.530

FY	2022
収益:	HKD2.27B
総利益:	HKD1.09B (47.90 %)
EPS:	HKD2.01

FY	2021
収益:	HKD1.52B
総利益:	HKD739.12M (48.73 %)
EPS:	HKD1.255

Financial Reports:

No articles found.

Joinn Laboratories Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0.420 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.440 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Joinn Laboratories Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.34 - Stable (13.11%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.214	2021-06-23
Last Dividend	HKD0.440	2023-06-20
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	HKD1.074	--
Avg. Dividend % Per Year	0.00%	--
Score	2.86	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.34
Div. Directional Score	7.76	--

Next Divdend (Est)
(2025-05-12)

HKD0.460 Estimate 3.06 %

Dividend Stability

0.24 Very Poor

Dividend Score

2.86

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6886.HK	Ex Dividend Junior	2023-07-12	Annually	0.00%
1980.HK	No Dividend Player	2023-09-13	Sporadic	0.00%
1045.HK	Ex Dividend Knight	2023-09-18	Semi-Annually	0.00%
0119.HK	Ex Dividend Junior	2023-06-09	Sporadic	0.00%
3390.HK	Ex Dividend Junior	2023-10-10	Annually	0.00%
1596.HK	Ex Dividend Junior	2023-05-31	Annually	0.00%
0635.HK	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%
9922.HK	Ex Dividend Knight	2023-06-07	Annually	0.00%
2177.HK	Ex Dividend Junior	2023-09-12	Sporadic	0.00%
1177.HK	Ex Dividend Knight	2023-10-04	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.167	1.500	6.66	9.99	[0 - 0.5]
returnOnAssetsTTM	0.0396	1.200	8.68	10.00	[0 - 0.3]
returnOnEquityTTM	0.0483	1.500	-0.575	-0.862	[0.1 - 1]
payoutRatioTTM	0.540	-1.000	4.60	-4.60	[0 - 1]
currentRatioTTM	4.85	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.52	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	1.951	1.500	0.272	0.408	[0.2 - 2]
debtRatioTTM	0.00692	-1.500	9.88	-10.00	[0 - 0.6]
interestCoverageTTM	5 875.11	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	1.081	2.00	9.64	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.828	2.00	9.59	10.00	[0 - 20]
debtEquityRatioTTM	0.00839	-1.500	9.97	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.426	1.000	6.23	6.23	[0.2 - 0.8]
operatingProfitMarginTTM	0.213	1.000	7.73	7.73	[0.1 - 0.6]
cashFlowToDebtRatioTTM	11.87	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.237	0.800	-1.753	-1.403	[0.5 - 2]
Total Score				11.17

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	14.47	1.000	8.64	0	[1 - 100]
returnOnEquityTTM	0.0483	2.50	-0.369	-0.862	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.828	2.00	9.72	10.00	[0 - 30]
dividendYielPercentageTTM	5.84	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.081	2.00	9.64	10.00	[0 - 30]
payoutRatioTTM	0.540	1.500	4.60	-4.60	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.347	1.000	3.83	0	[0.1 - 0.5]
Total Score				4.34

Joinn Laboratories

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers investment management and cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.